...
...
Next Story

Diet soda could prevent recurrence of colon cancer, reduce risk of death

Updated on: Jul 20, 2018, 16:51:23 IST
Press Trust of India | By
Prefer HTon Google
A study shows that artificially sweetened beverages are associated with a significantly lower risk of colon cancer. (Shutterstock)
A study shows that artificially sweetened beverages are associated with a significantly lower risk of colon cancer. (Shutterstock)
Advertisement

Artificially sweetened beverages, such as diet soda, could be associated with a lower risk of colon cancer recurrence and cancer death, says a new study.

Drinking artificially sweetened beverages is associated with a significantly lower risk of colon cancer recurrence and cancer death, a study claims. “Artificially sweetened drinks have a checkered reputation in the public because of purported health risks that have never really been documented,” said Charles S Fuchs from Yale University in the US.

“Our study clearly shows they help avoid cancer recurrence and death in patients who have been treated for advanced colon cancer, and that is an exciting finding,” said Fuchs, senior author of the study published in the journal PLOS ONE.

“Factors such as obesity, sedentary lifestyle, a diet linked to diabetes — all of which lead to an excess energy balance — are known risk factors. We now find that, in terms of colon cancer recurrence and survival, use of artificially sweetened drinks is not a health risk, but is, in this study, a healthier choice,” Fuchs said.

Researchers found that in the 1,018-patient analysis, those participants who drank one or more 12-ounce serving of artificially sweetened beverages per day experienced a 46% lower risk of cancer recurrence or death, compared to those who didn’t drink these beverages. These “soft drinks” were defined as caffeinated colas, caffeine-free colas, and other carbonated beverages (such as diet ginger ale).

This research follows on the heels of a number of publications of studies that prospectively followed stage III colon cancer patients enrolled in a US National Cancer Institute-supported clinical trial testing two different forms of post-surgical chemotherapy.

Follow @htlifeandstyle for more

 
Catch every big hit, every wicket with Crick-it, a one stop destination for Live Scores, Match Stats, Quizzes, Polls & much more. Explore now!.

Catch your daily dose of Fashion, Taylor Swift, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs.
Catch every big hit, every wicket with Crick-it, a one stop destination for Live Scores, Match Stats, Quizzes, Polls & much more. Explore now!.

Catch your daily dose of Fashion, Taylor Swift, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs.
SHARE THIS ARTICLE ON